A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• LinJWuLBaiXCombination treatment including targeted therapy for advanced hepatocellular carcinomaOncotarget2016743710367105127626176
   PubMedGoogle Scholar
• MarginiCDufourJFThe story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatmentLiver Int201636331732426601627
   PubMed Web of Science ®Google Scholar
• ZhaoJZhangHWeiLXieSSuoZComparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparisonOncotarget201789151011511327835871
   PubMedGoogle Scholar
• BaloghJVictorD3rdAshamEHHepatocellular carcinoma: a reviewJ Hepatocell Carcinoma20163415327785449
   PubMed Web of Science ®Google Scholar
• QiXWangDSuCLiHGuoXHepatic resection vs transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: a systematic review and meta-analysisOncotarget2015621187151873326243835
   PubMedGoogle Scholar
• ZhangYFHoMHumanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinomaSci Rep201663387827667400
   PubMed Web of Science ®Google Scholar
• ColagrandeSInghilesiALAburasSTalianiGGNardiCMarraFChallenges of advanced hepatocellular carcinomaWorld J Gastroenterol201622347645765927678348
   PubMed Web of Science ®Google Scholar
• NakamotoYPromising new strategies for hepatocellular carcinomaHepatol Res201747425126527558453
   PubMedGoogle Scholar
• ChauhanRLahiriNTissue- and serum-associated biomarkers of hepatocellular carcinomaBiomark Cancer20168Suppl 1375527398029
   PubMedGoogle Scholar
• ZhengJFLuJWangXZGuoWHZhangJXComparative metabolomic profiling of hepatocellular carcinoma cells treated with sorafenib monotherapy vs. sorafenib-everolimus combination therapyMed Sci Monit2015211781179126092946
   PubMed Web of Science ®Google Scholar
• JianyongLJinjingZJingchengHHepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrenceOncotarget2016727425984260726981887
   PubMedGoogle Scholar
• TangSTanGJiangXAn artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cellsOncotarget2016745732577326927689326
   PubMed Web of Science ®Google Scholar
• MizuguchiYTakizawaTYoshidaHUchidaEDysregulated miRNA in progression of hepatocellular carcinoma: a systematic reviewHepatol Res201646539140626490438
   PubMed Web of Science ®Google Scholar
• LiuLNLiDDXuHXZhengSGZhangXPRole of microRNAs in hepatocellular carcinomaFront Biosci (Landmark Ed)2015201056106725961544
   PubMedGoogle Scholar
• LiuLYeJXQinYZChenQHGeLYEvaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancerInt J Clin Exp Med2015812222272223626885198
   PubMed Web of Science ®Google Scholar
• JinKLiTSanchez-DuffhuesGZhouFZhangLInvolvement of inflammation and its related microRNAs in hepatocellular carcinomaOncotarget2017813221452216527888618
   PubMedGoogle Scholar
• LeeYSKimHKimHWHigh expression of MicroRNA-196a indicates poor prognosis in resected pancreatic neuroendocrine tumorMedicine (Baltimore)20159450e222426683934
   PubMed Web of Science ®Google Scholar
• ZhangXTangWChenGAn encapsulation of gene signatures for hepatocellular carcinoma, MicroRNA-132 predicted target genes and the corresponding overlapsPLoS One2016117e015949827467251
   PubMed Web of Science ®Google Scholar
• ZhangXTangWLiRDownregulation of microRNA-132 indicates progression in hepatocellular carcinomaExp Ther Med20161242095210127698698
   PubMedGoogle Scholar
• WeiYHeRWuYComprehensive investigation of aberrant microRNA profiling in bladder cancer tissuesTumour Biol2016379125551256927350368
   PubMedGoogle Scholar
• HeRYangLLinXMiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1Int J Clin Exp Pathol2015812156321564126884832
   PubMed Web of Science ®Google Scholar
• BrunettiORussoAScarpaAMicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Oncotarget2015627233232334126259238
   PubMedGoogle Scholar
• LiCChenXHuangJSunQWangLClinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarctionEur J Med Res2015205826044724
   PubMed Web of Science ®Google Scholar
• DuDSYangXZWangQEffects of CDC42 on the proliferation and invasion of gastric cancer cellsMol Med Rep201613155055426549550
   PubMed Web of Science ®Google Scholar
• GiuliettiMOcchipintiGPrincipatoGPivaFIdentification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysisCell Oncol2017402181192
   PubMed Web of Science ®Google Scholar
• HuaLZhouPLiLLiuHYangZPrioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profilingJ Theor Biol201333111123619378
   PubMedGoogle Scholar
• YepesSLopezRAndradeRERodriguez-UrregoPALopez-KleineLTorresMMCo-expressed miRNAs in gastric adenocarcinomaGenomics201610829310127422560
   PubMed Web of Science ®Google Scholar
• YuMLinYZhouYMiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4Onco Targets Ther201694705471427536132
   PubMed Web of Science ®Google Scholar
• ZhouSYeWZhangYmiR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathwayAm J Transl Res2016872992300227508019
   PubMed Web of Science ®Google Scholar
• CaoTLiHHuYMaDCaiXmiR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3Tumour Biol20143511107591076425073510
   PubMedGoogle Scholar
• DangYLuoDRongMChenGUnderexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-METPLoS One201384e6105423593387
   PubMed Web of Science ®Google Scholar
• RongMHeRDangYChenGExpression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissuesUps J Med Sci20141191192424172202
   PubMed Web of Science ®Google Scholar
• ChenGUmeloIALvSmiR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cellsPLoS One201383e6031723555954
   PubMed Web of Science ®Google Scholar
• HuangWTWangHLYangHLower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico studyOnco Targets Ther201695163518027578984
   PubMed Web of Science ®Google Scholar
• HuangWTChenZXHeRQClinicopathological role of miR- 30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysisOnco Targets Ther201695061507127574447
   PubMed Web of Science ®Google Scholar
• LiuYRenFLuoYRongMChenGDangYDown-regulation of MiR-193a-3p dictates deterioration of HCC: a clinical real-time qRT-PCR studyMed Sci Monit2015212352236026263159
   PubMedGoogle Scholar
• LiuYRenFRongMLuoYDangYChenGAssociation between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissuesCancer Cell Int2015156226109910
   PubMed Web of Science ®Google Scholar
• GanTQTangRXHeRQDangYWXieYChenGUpregulated MiR-1269 in hepatocellular carcinoma and its clinical significanceInt J Clin Exp Med20158171472125785048
   PubMed Web of Science ®Google Scholar
• RongMChenGDangYIncreased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitroBMC Cancer2013132123320393
   PubMed Web of Science ®Google Scholar
• IoannidisJPPatsopoulosNAEvangelouEUncertainty in heterogeneity estimates in meta-analysesBMJ2007335762691491617974687
   PubMed Web of Science ®Google Scholar
• DweepHGretzNmiRWalk2.0: a comprehensive atlas of microRNA-target interactionsNat Methods201512869726226356
   PubMed Web of Science ®Google Scholar
• VlachosISParaskevopoulouMDKaragkouniDDIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactionsNucleic Acids Res201543Database issueD153D15925416803
   PubMed Web of Science ®Google Scholar
• ChouCHChangNWShresthaSmiRTarBase 2016: updates to the experimentally validated miRNA-target interactions databaseNucleic Acids Res201644D1D239D24726590260
   PubMed Web of Science ®Google Scholar
• FanYSiklenkaKAroraSKRibeiroPKimminsSXiaJmiRNet – dissecting miRNA-target interactions and functional associations through network-based visual analysisNucleic Acids Res201644W1W135W14127105848
   PubMed Web of Science ®Google Scholar
• Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
   PubMed Web of Science ®Google Scholar
• SzklarczykDFranceschiniAWyderSSTRING v10: protein-protein interaction networks, integrated over the tree of lifeNucleic Acids Res201543Database issueD447D45225352553
   PubMed Web of Science ®Google Scholar
• ChackoSSamantaSHepatocellular carcinoma: a life-threatening diseaseBiomed Pharmacother2016841679168827823920
   PubMed Web of Science ®Google Scholar
• PanYZhangJFuHShenLmiR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition processOnco Targets Ther201696247625527785072
   PubMed Web of Science ®Google Scholar
• JinJWangYXuYMicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2J Gene Med2016
   Google Scholar
• LiuMGaoJHuangQJinYWeiZDownregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expressionOncol Lett20161163772377627313692
   PubMedGoogle Scholar
• LiuFChenNXiaoRWangWPanZmiR-144–3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8Biochem Biophys Res Commun20164801879327717821
   PubMedGoogle Scholar
• CaiSDChenJSXiZWZhangLJNiuMLGaoZYMicroRNA144 inhibits migration and proliferation in rectal cancer by downregulating ROCK1Mol Med Reps201512573967402
   PubMedGoogle Scholar
• GaoZLiuRLiaoJPossible tumor suppressive role of the miR-144/451 cluster in esophageal carcinoma as determined by principal component regression analysisMole Med Rep201614438053813
   PubMed Web of Science ®Google Scholar
• ShaoYLiPZhuSTMiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2Oncotarget2016712151731518626959737
   PubMedGoogle Scholar
• SharmaPSarayaASharmaRPotential diagnostic implications of miR-144 overexpression in human oesophageal cancerIndian J Medi Res2016143SupplS91S103
   PubMedGoogle Scholar
• JankuFKasebAOTsimberidouAMWolffRAKurzrockRIdentification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencingOncotarget20145103012302224931142
   PubMedGoogle Scholar
• YangZZhangYWangLA feedback inhibition between miRNA-127 and TGFbeta/c-Jun cascade in HCC cell migration via MMP13PLoS One201386e6525623762330
   PubMedGoogle Scholar
• TsutsuiMIizukaNMoribeTMethylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinomaClin Chim Acta20104117–851652020064498
   PubMed Web of Science ®Google Scholar
• ZhaoRWuYWangTElevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patientsOncol Lett20151053026303426722284
   PubMedGoogle Scholar
• HuangQLiJXingJCD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathwayJ Hepatol201461485986624801417
   PubMedGoogle Scholar
• DongYQLuCWZhangLYangJHameedWChenWToll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathwayMol Immunol2015682 Pt C67168326589455
   PubMedGoogle Scholar
• YangXZhangXFLuXMicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathwayHepatology20145951874188524259426
   PubMed Web of Science ®Google Scholar
• GuoYYingLTianYmiR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signalingFEBS J2013280184531453823815091
   PubMed Web of Science ®Google Scholar
• GuHLiuMDingCHypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1Cancer Med2016561174118226990493
   PubMed Web of Science ®Google Scholar